On September 19, 2023, a group of authors consisting of health care partner Mark Barnes, health care associates Minal Caron and Sarah Dohan, and Barbara Bierer, faculty director of the Multi-Regional Clinical Trials Center of Brigham and Women’s Hospital and Harvard, published an article in Accountability in Research. This article delves into the definitions of ‘recklessness’ in research misconduct proceedings.
The authors focus on various practices and industries related to healthcare and life sciences. These practices include health care, biomedical research (human, animal, and bench science), educational institutions, digital health, FDA regulatory, and health privacy & security.
Within the article, the authors present a framework for evaluating the circumstances in which past supervisory conduct should be considered ‘reckless’. This framework serves as a basis for determining research misconduct. The aim is to establish clear guidelines for identifying and addressing instances of negligence or recklessness in the field of research.
By providing these definitions and guidelines, the authors contribute to promoting accountability and integrity in research practices. Their insights serve as a valuable resource for those involved in the healthcare and life sciences industries.
/cloudfront-us-east-1.images.arcpublishing.com/gray/PG6XELIX5ZHOTBMOU65H4DV6SE.jpg)
